english.prescrire.org > Spotlight > "Spotlight" > The EMA can still do more to improve official drug information documents

"Spotlight"

The EMA can still do more to improve official drug information documents

 Advancing Healthcare Policy  In August 2025, Prescrire responded to a public consultation by the European Medicines Agency (EMA) concerning summaries of product characteristics (SmPCs) and package leaflets.
Full article available for download (FREE)

 ©Prescrire 1 October 2026

Source: "The EMA can still do more to improve official drug information documents" Prescrire Int 2026; 35 (285): 251. FREE.

Filet

Enjoy full access to Prescrire International, and support independent information

 

Share
Share on  Facebook  
 
 
See also:
 
"EMA: proposed Key
Information Section
in the package leaflet"
Prescrire Int 2026;
35 (280): 109. 
Subscribers only